BR112017024399A2 - uma composição farmacêutica antiviral de uso tópico - Google Patents

uma composição farmacêutica antiviral de uso tópico

Info

Publication number
BR112017024399A2
BR112017024399A2 BR112017024399A BR112017024399A BR112017024399A2 BR 112017024399 A2 BR112017024399 A2 BR 112017024399A2 BR 112017024399 A BR112017024399 A BR 112017024399A BR 112017024399 A BR112017024399 A BR 112017024399A BR 112017024399 A2 BR112017024399 A2 BR 112017024399A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
antiviral pharmaceutical
topical antiviral
topical
lipid
Prior art date
Application number
BR112017024399A
Other languages
English (en)
Other versions
BR112017024399B1 (pt
Inventor
Luis Alberto Argañarás
Original Assignee
Quim Luar S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quim Luar S R L filed Critical Quim Luar S R L
Publication of BR112017024399A2 publication Critical patent/BR112017024399A2/pt
Publication of BR112017024399B1 publication Critical patent/BR112017024399B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

composição farmacêutica antiviral de uso tópico uma composição farmacêutica antiviral de uso tópico. uma composição farmacêutica antiviral de uso tópico contra vírus com invólucro lipídico que compreende como princípios ativos um copolímero catiônico, contendo grupos aminos terciários, e um tensioativo catiônico contendo grupos amônios quaternários.
BR112017024399-7A 2015-05-15 2016-05-13 Composição farmacêutica antiviral de uso tópico BR112017024399B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ARP20150101519 2015-05-15
ARP150101519A AR100459A1 (es) 2015-05-15 2015-05-15 Una composición farmacéutica antiviral de uso tópico
PCT/ES2016/070365 WO2016185069A1 (es) 2015-05-15 2016-05-13 Una composición farmacéutica antiviral de uso tópico

Publications (2)

Publication Number Publication Date
BR112017024399A2 true BR112017024399A2 (pt) 2019-02-05
BR112017024399B1 BR112017024399B1 (pt) 2022-06-07

Family

ID=57319498

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017024399-7A BR112017024399B1 (pt) 2015-05-15 2016-05-13 Composição farmacêutica antiviral de uso tópico

Country Status (11)

Country Link
US (1) US10478452B2 (pt)
EP (1) EP3295934B1 (pt)
AR (1) AR100459A1 (pt)
BR (1) BR112017024399B1 (pt)
CL (1) CL2017002796A1 (pt)
CO (1) CO2017011297A2 (pt)
ES (1) ES2915824T3 (pt)
IL (1) IL255635A (pt)
MX (1) MX2017014162A (pt)
PE (1) PE20180396A1 (pt)
WO (1) WO2016185069A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022219944A1 (ja) * 2021-04-16 2022-10-20 株式会社日本触媒 抗コロナウイルス剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3743727A (en) * 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
US4902720A (en) * 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
BRPI0014271B1 (pt) * 1999-09-24 2021-06-22 Janssen Pharmaceutica N.V. Partícula consistindo em uma dispersão de sólidos, uso da dita partícula, dispersão de sólidos, forma de dosagem farmacêutica, bem como processos de preparação de dita partícula, dispersão e forma de dosagem
US6855341B2 (en) 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
ITMI20051417A1 (it) * 2005-07-22 2007-01-23 Mipharm S P A Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
US8119115B2 (en) * 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
US20140328895A1 (en) * 2011-03-29 2014-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Film-forming composition for a ph-dependant sustained release of the active agent

Also Published As

Publication number Publication date
MX2017014162A (es) 2018-06-20
WO2016185069A1 (es) 2016-11-24
US20180250327A1 (en) 2018-09-06
CO2017011297A2 (es) 2018-01-31
IL255635A (en) 2018-01-31
EP3295934A1 (en) 2018-03-21
EP3295934B1 (en) 2022-03-02
ES2915824T3 (es) 2022-06-27
EP3295934A4 (en) 2019-01-02
BR112017024399B1 (pt) 2022-06-07
CL2017002796A1 (es) 2018-07-13
AR100459A1 (es) 2016-10-05
PE20180396A1 (es) 2018-02-28
US10478452B2 (en) 2019-11-19

Similar Documents

Publication Publication Date Title
BR112017028318A2 (pt) compostos antibacterianos
CO2017001994A2 (es) Compuestos activos hacia bromodominios
BR112017002811A2 (pt) compostos de pirrolopirimidina usados como agonista de tlr7
BR112016026291A2 (pt) Derivados do ácido borônico e usos terapêuticos dos mesmos
BR112015014482A2 (pt) vacinas para vírus influenza e seus usos
CL2016000381A1 (es) Compuestos antivirales
BR112017026650A2 (pt) composições de metilobacterium antifúngicas e métodos de utilização
BR112015027321A8 (pt) Compostos e composições para modular a expressão de apolipoproteína(a) e seus usos
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
CL2016001973A1 (es) Derivados de nucleosido sustituidos con 4' -difluorometilo como inhibidores de la replicación de arn de la influenza.
BR112016006048A8 (pt) composições antimicrobianas
BR112019000693A2 (pt) composições de muc1- car e métodos para uso
CR20170425A (es) Nuevas proteínas específicas para pioverdina y pioquelina
BR112017025781A2 (pt) derivados de 2-(pirazolopiridin-3-il)pirimidina como inibidores de jak
BR112019004496A2 (pt) estabilizantes de mastócitos para tratamento de hipercitocinemia e infecção viral
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
BR112016022046A2 (pt) Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
BR112016005417A8 (pt) "compostos derivados de desoxinojirimicina, composição farmacêutica e seus usos"
BR112017015116A2 (pt) derivados de (r)-2-metil-piperazina como moduladores do receptor cxcr3
BR112017014414A2 (pt) formulação farmacêutica
BR112017023425A2 (pt) combinações terapêuticas de terapias antivirais e anti-inflamatórias
CR20150145A (es) Composiciones con matriz de resina fundida en caliente
BR112018071722A2 (pt) uso do amino açúcar como plastificante
MX2017006476A (es) Terapia de combinacion efectiva contra microorganismos, que incluye microorganismos resistentes a farmacos.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/05/2016, OBSERVADAS AS CONDICOES LEGAIS